Black Rock Inc. Merus N.V. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Merus N.V. stock. As of the latest transaction made, Black Rock Inc. holds 1,525,749 shares of MRUS stock, worth $77.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,525,749
Previous 1,467,924
3.94%
Holding current value
$77.7 Million
Previous $66.1 Million
36.58%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MRUS
# of Institutions
200Shares Held
60.1MCall Options Held
290KPut Options Held
227K-
Rtw Investments, LP New York, NY4.17MShares$212 Million3.32% of portfolio
-
Commodore Capital LP New York, NY3.2MShares$163 Million16.98% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.75MShares$140 Million3.41% of portfolio
-
Samlyn Capital, LLC New York, NY2.32MShares$118 Million2.45% of portfolio
-
Franklin Resources Inc San Mateo, CA2.26MShares$115 Million0.03% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.34B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...